Lumen director granted 25,197 company shares
MCMILLAN STEPHEN reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
MCMILLAN STEPHEN reported acquisition or exercise transactions in this Form 4 filing.
Lumen Technologies director Stephen McMillan received an equity grant of company stock. He was awarded 25,197 shares of Lumen Technologies common stock at a reference price of $9.44 per share. Following this grant, he holds 76,591 shares directly. The restricted stock will vest on May 21, 2027, aligning his compensation with longer-term company performance.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 25,197 | $9.44 | $238K |
Footnotes (1)
- F1. This grant of restricted stock will vest on May 21, 2027.
Key Figures
Key Terms
restricted stock financial
Grant, award, or other acquisition financial
Common Stock financial
transaction code "A" financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Lumen Technologies (LUMN) director Stephen McMillan report on this Form 4?
Is the Stephen McMillan Form 4 for Lumen Technologies (LUMN) a stock purchase or a grant?
What transaction code appears on Stephen McMillan’s Lumen Technologies (LUMN) Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.